Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis.

Hexavalent chromium [cr(VI)] Long non-coding RNA ABHD11-AS1 Lung cancer Non-canonical NFκB pathway PD-L1

Journal

Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053

Informations de publication

Date de publication:
23 Mar 2024
Historique:
received: 12 12 2023
revised: 07 03 2024
accepted: 20 03 2024
medline: 26 3 2024
pubmed: 26 3 2024
entrez: 25 3 2024
Statut: aheadofprint

Résumé

Lung cancer is the leading cause of cancer-related death worldwide; however, the mechanism of lung carcinogenesis has not been clearly defined. Chronic exposure to hexavalent chromium [Cr(VI)], a common environmental and occupational pollutant, causes lung cancer, representing an important lung cancer etiology factor. The mechanism of how chronic Cr(VI) exposure causes lung cancer remains largely unknown. By using cell culture and mouse models and bioinformatics analyses of human lung cancer gene expression profiles, this study investigated the mechanism of Cr(VI)-induced lung carcinogenesis. A new mouse model of Cr(VI)-induced lung carcinogenesis was developed as evidenced by the findings showing that a 16-week Cr(VI) exposure (CaCrO

Identifiants

pubmed: 38527692
pii: S0304-3835(24)00220-9
doi: 10.1016/j.canlet.2024.216827
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

216827

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Po-Shun Wang (PS)

Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA.

Zulong Liu (Z)

Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA.

Osama Sweef (O)

Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Abdullah Farhan Saeed (AF)

Division of Cancer Biology, Department of Medicine, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Thomas Kluz (T)

Department of Environment Medicine, New York University School of Medicine, New York, NY, USA.

Max Costa (M)

Department of Environment Medicine, New York University School of Medicine, New York, NY, USA.

Kenneth R Shroyer (KR)

Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA; Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA.

Kazuya Kondo (K)

Department of Oncological Medical Services, Graduate School of Biomedical Sciences, Tokushima University Graduate School, Tokushima City, 770-8509, Japan.

Zhishan Wang (Z)

Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA; Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA.

Chengfeng Yang (C)

Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA; Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA. Electronic address: chengfeng.yang@stonybrook.edu.

Classifications MeSH